|

Analysis of Biomarkers From Patients With Chorioretinal Diseases

RECRUITINGSponsored by Kyungpook National University Hospital
Actively Recruiting
SponsorKyungpook National University Hospital
Started2012-04
Est. completion2028-02
Eligibility
Age20 Years – 80 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT02026843

Summary

This study was conducted to investigate the levels of ocular biomarkers from the patients with chorioretinal diseases including diabetic retinopathy, retinal vascular diseases, age-related macular degeneration (dry and wet), and retinal degeneration.

Eligibility

Age: 20 Years – 80 YearsHealthy volunteers accepted
Inclusion Criteria:

* age over 20 years
* patients requiring ophthalmologic treatments for different degrees of decreasing of visual acuity.
* patients with chorioretinal diseases including diabetic retinopathy, retinal vascular diseases, age-related macular degeneration (dry and wet), and retinal degeneration.
* control patients asking cataract surgery or vitrectomy for posterior segment nonproliferative disorders.

Exclusion Criteria:

* under the age of 20 years
* patients that received any anti-vascular endothelial growth factor agent for proliferative disease before taking sample of aqueous humor
* patients that did not signed the informed consent of the trial
* patients with intraocular inflammations or infections that requiring any pharmaceutical agent
* patients with recent ocular trauma

Conditions3

DiabetesDiabetic RetinopathyMacular Degeneration

Browse More Trials

Diabetes trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.